Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks) +++ MICROBOT Aktie +4,25%

ORGANIGRAM Aktie

 >ORGANIGRAM Aktienkurs 
1.43 EUR    +2.1%    (Tradegate)
Ask: 1.42 EUR / 5600 Stück
Bid: 1.37 EUR / 5900 Stück
Tagesumsatz: 13727 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
ORGANIGRAM Aktie über LYNX handeln
>ORGANIGRAM Performance
1 Woche: -0,7%
1 Monat: +14,4%
3 Monate: +18,2%
6 Monate: 0%
1 Jahr: 0%
laufendes Jahr: 0%
>ORGANIGRAM Aktie
Name:  ORGANIGRAM GLOBAL INC.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA68617J1003 / A415A3
Symbol/ Ticker:  0OG (Frankfurt) / OGI (NASDAQ)
Kürzel:  FRA:0OG, ETR:0OG, 0OG:GR, NASDAQ:OGI
Index:  -
Webseite:  https://www.organigram.ca..
Profil:  -
Marktkapitalisierung:  187.79 Mio. EUR
Unternehmenswert:  139.91 Mio. EUR
Umsatz:  139.81 Mio. EUR
EBITDA:  -39.15 Mio. EUR
Nettogewinn:  4.85 Mio. EUR
Gewinn je Aktie:  0.02 EUR
Schulden:  5.71 Mio. EUR
Liquide Mittel:  53.11 Mio. EUR
Operativer Cashflow:  3.27 Mio. EUR
Bargeldquote:  0.8
Umsatzwachstum:  26.92%
Gewinnwachstum:  -
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  ORGANIGRAM
Letzte Datenerhebung:  10.09.25
>ORGANIGRAM Kennzahlen
Aktien/ Unternehmen:
Aktien: 133.88 Mio. St.
Frei handelbar: 67.51%
Rückkaufquote: -27.39%
Mitarbeiter: 898
Umsatz/Mitarb.: 0.11 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 40.02%
Bewertung:
KGV: 112.27
KGV lG: 26.18
KUV: 1.36
KBV: 0.74
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 2.93%
Gewinnmarge: 3.47%
Operative Marge: -35.19%
Managementeffizenz:
Gesamtkaprendite: 1.69%
Eigenkaprendite: 2.28%
>ORGANIGRAM Peer Group

Es sind 186 Aktien bekannt.
 
13.08.25 - 12:09
Organigram Holdings reports Q3 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.08.25 - 12:03
Organigram Reports Record Third Quarter Fiscal 2025 Results (Business Wire)
 
Second consecutive quarter of record revenue, strong adjusted EBITDA growth, Free Cash Flow, and continued international expansionTORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its record results for the third quarter ended June 30, 2025 (“Q3 Fiscal 2025” or “Q3”). Q3 FISCAL 2025 HIGHLIGHTS Record Gross Revenue: $110.2 million (+73% year-over-year, +7.2% sequential). Record Net Revenue: $70.8 million (+72% year-over-year, +7.9% sequential). International Revenue: $7.4 million (+208% year-over-year, +21% sequential). Adjusted EBITDA2: $5.7 million (+64% year-over-year, +16% sequential). Free Cash Flow2: $5.0 million versus ($4.8) million in the prior year period. Motif Synergies: $4.2 million to date, approximately $11 million annualized; on track to hit $15 million target within 24 months of acquisition. Total Cash: $85.9 million3, including $35.9 million of u...
12.08.25 - 16:24
Organigram Holdings Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.08.25 - 12:06
Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 (Business Wire)
 
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its third quarter fiscal 2025 ended June 30, 2025, on Wednesday, August 13, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Wednesday, August 13, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use this link: https://registrations.events/direct/Q4I9676685 To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call. To access the webcast: https://events.q4inc.com/attendee/755647987Participants will receive their details via email. A replay of ...
08.07.25 - 12:33
Organigram Global scales US presence, expands hemp-derived THC beverage portfolio (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.05.25 - 02:33
Organigram CEO To Retire After Building Canada€s Largest Cannabis Brand: Here€s What€s Next (Benzinga)
 
Organigram CEO Beena Goldenberg to retire after leading company to #1 in Canada and launching U.S. and global expansion plans. read more...
27.05.25 - 12:30
Organigram CEO Beena Goldenberg to retire (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
27.05.25 - 12:06
Organigram Global Announces CEO Succession Plan (Business Wire)
 
Beena Goldenberg, CEO to retire at the end of the Company's fiscal year Board of Directors expresses confidence in the Company's strategic direction and leadership team Comprehensive CEO selection process will be initiated to identify a successor TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the “Board”) to advance Organigram's strategic objectives, including international expansion, and to ensure an effective transition. Since joining Organigram as CEO in September 2021, Ms. Goldenberg successfully led the organization's growth and transformation from a cannabis company with $80M in net revenue to becoming t...
01.04.25 - 23:31
XFRA: NEW INSTRUMENT AVAILABLE - 02.04.2025 - CA68617J1003 (XETRA)
 
Das Instrument 0OG CA68617J1003 ORGANIGRAM GLOBAL INC. EQUITY hat seinen ersten Handelstag am 02.04.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument 0OG CA68617J1003 ORGANIGRAM GLOBAL INC. EQUITY has its first trading date on 02.04.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
01.04.25 - 17:06
XFRA: ISIN Change (XETRA)
 
Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen CA50203F2052 Skycap Investment Holdings Inc. 01.04.2025 CA83086W1023 Skycap Investment Holdings Inc. 02.04.2025 Tausch 1:1 CA29872T1003 Euro Manganese Inc. 01.04.2025 CA29872T2092 Euro Manganese Inc. 02.04.2025 Tausch 5:1 US98979Y1064 Zozo Inc. 01.04.2025 US98979Y2054 Zozo Inc. 02.04.2025 Tausch 5:3 CA68620P7056 Organigram Global Inc. 01.04.2025 CA68617J1003 Organigram Global Inc. 02.04.2025 Tausch 1:1...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Weit besser ist′s, sie einzuengen, daß man sie wie Kinder halten, wie Kinder zu ihrem Besten leiten kann. Glaube nur, ein Volk wird nicht alt, nicht klug, ein Volk bleibt immer kindisch. - Johann Wolfgang von Goethe
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!